Can esophageal erythema (mild redness) observed during gastroscopy be caused by escitalopram (citalopram), and if so, what is the underlying mechanism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Escitalopram can potentially cause esophageal erythema (mild redness) observed during gastroscopy, and the underlying mechanism is related to its effects on gastrointestinal motility and secretion as a selective serotonin reuptake inhibitor (SSRI). As a SSRI, escitalopram increases serotonin levels, which can affect gastrointestinal motility and secretion, influencing acid production and blood flow to the gastric mucosa 1. Additionally, escitalopram may reduce prostaglandin synthesis, which normally protects the gastric mucosa, leading to increased vulnerability to irritation 2. Some patients also experience reduced gastric emptying while taking SSRIs, allowing stomach acid to remain in contact with the esophagus for longer periods, potentially causing erythema. The most recent and highest quality study on the use of escitalopram in functional gastrointestinal disorders found that it could be a safe and effective treatment, but also highlighted the importance of managing factors leading to poor compliance 3. If you're experiencing symptoms along with esophageal erythema, discuss with your doctor about possibly adding a proton pump inhibitor like omeprazole or pantoprazole for gastric protection, adjusting your escitalopram dosage, or considering an alternative antidepressant with fewer gastrointestinal effects. Key points to consider:

  • Escitalopram's effects on serotonin levels and gastrointestinal motility and secretion
  • Potential reduction in prostaglandin synthesis and increased vulnerability to irritation
  • Importance of managing factors leading to poor compliance
  • Possible addition of a proton pump inhibitor or adjustment of escitalopram dosage.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.